John Cox
Chief Executive Officer bij DYNE THERAPEUTICS, INC.
Vermogen: 170 569 $ op 31-07-2023
Oorsprong van het eerstegraads netwerk van John Cox
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
202
| Public Company | Pharmaceuticals: Major | 202 |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ.
44
| Subsidiary | Pharmaceuticals: Major | 44 |
| Public Company | Biotechnology | 24 | |
| Public Company | Pharmaceuticals: Major | 21 | |
| Public Company | Biotechnology | 20 | |
| Subsidiary | Biotechnology | 14 | |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA.
10
| Holding Company | Miscellaneous Commercial Services | 10 |
Minovia Therapeutics Ltd.
 Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Covance Biotechnology Services, Inc.
 Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Covance Biotechnology Services, Inc. develops pharmaceutical products. The company offers two microbiology laboratories, one for mycoplasma analysis, and a second for molecular biology. It provides services to biomolecules, including recombinant proteins, monoclonal antibodies, vaccines, blood products, and gene therapy products. The company was founded by Richard J. Hawkins, V. Bryan Lawlis, and John A. Scarlett in 1995 and is headquartered in Princeton, NJ.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Torque Therapeutics, Inc.
 Torque Therapeutics, Inc. BiotechnologyHealth Technology Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA.
6
| Subsidiary | Biotechnology | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met John Cox via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Sales & Marketing | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| REVVITY, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal Comptroller/Controller/Auditor | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| BG MEDICINE, INC. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Director/Board Member Chairman Director/Board Member | |
| Boston University | College/University | Undergraduate Degree Masters Business Admin Graduate Degree | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor Consultant / Advisor | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| Bentley University | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Masters Business Admin | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Director/Board Member Graduate Degree Undergraduate Degree | |
| The University of Chicago | College/University | Graduate Degree Doctorate Degree Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| New York University | College/University | Undergraduate Degree Doctorate Degree | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
| Rensselaer Polytechnic Institute | College/University | Undergraduate Degree Graduate Degree Masters Business Admin | |
| University of California, Berkeley | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
| University of Illinois | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
Whitehead Institute for Biomedical Research
 Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| THERMO FISHER SCIENTIFIC | Medical Specialties | Director of Finance/CFO Director/Board Member Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Chief Executive Officer Director/Board Member Chief Executive Officer | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| VERASTEM, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| Centers for Therapeutic Innovation | Chief Operating Officer Founder | ||
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| DICE THER | Biotechnology | President Director/Board Member Corporate Secretary | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact Comptroller/Controller/Auditor | |
| FOGHORN THERAPEUTICS INC. | Biotechnology | Founder Director/Board Member Human Resources Officer | |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
| POIT BIOP | Pharmaceuticals: Major | Director/Board Member President Director/Board Member Director/Board Member | |
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Elucida Oncology, Inc. operates as a biotechnology company which focuses on clinical research and development. The company was founded by Isaac Blech, Michelle Bradbury, Ulrich Weisner, and Steven Larson in 2014 and is headquartered in Monmouth Junction, NJ. | Biotechnology | Director/Board Member Chairman Chief Executive Officer | |
| SANA BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Founder Chief Tech/Sci/R&D Officer | |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 49 |
| Denemarken | 2 |
| Duitsland | 2 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 15 |
| Finance | 5 |
| Commercial Services | 4 |
| Miscellaneous | 2 |
Operationeel
| Director/Board Member | 555 |
| Corporate Officer/Principal | 219 |
| Independent Dir/Board Member | 180 |
| Chairman | 98 |
| Chief Executive Officer | 78 |
Sterkste connecties
| Insiders | |
|---|---|
| Douglas Cole | 44 |
| Stephen Oesterle | 37 |
| Eric Rowinsky | 36 |
| William Young | 32 |
| Shmuel Cabilly | 30 |
| Fred Hassan | 29 |
| Edward Hurwitz | 27 |
| Caroline Dorsa | 27 |
| Susan Hockfield | 26 |
| Stephen Sherwin | 26 |
| Stelios Papadopoulos | 26 |
| Alexander Denner | 25 |
| Jason Rhodes | 24 |
| Robert Ruffolo | 24 |
| Jose-Carlos Gutiérrez-Ramos | 24 |
